Glatting G - Search Results

1

The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for ¹⁷⁷Lu-Labeled PSMA Peptides.

Begum NJ, Thieme A, Eberhardt N, Tauber R, D'Alessandria C, Beer AJ, Glatting G, Eiber M, Kletting P. Begum NJ, et al. Among authors: glatting g. J Nucl Med. 2018 Jun;59(6):929-933. doi: 10.2967/jnumed.117.203505. Epub 2018 Feb 1. J Nucl Med. 2018. PMID: 29419479 Free article.

2

Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.

Reske SN, Grillenberger KG, Glatting G, Port M, Hildebrandt M, Gansauge F, Beger HG. Reske SN, et al. Among authors: glatting g. J Nucl Med. 1997 Sep;38(9):1344-8. J Nucl Med. 1997. PMID: 9293784 Free article.

3

Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: differences in dosimetry and biokinetics of 188Re- and 99mTc-labeled anti-NCA-95 MAbs.

Kotzerke J, Glatting G, Seitz U, Rentschler M, Neumaier B, Bunjes D, Duncker C, Dohr D, Bergmann L, Reske SN. Kotzerke J, et al. Among authors: glatting g. J Nucl Med. 2000 Mar;41(3):531-7. J Nucl Med. 2000. PMID: 10716329 Free article.

4

Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer.

Schirrmeister H, Glatting G, Hetzel J, Nüssle K, Arslandemir C, Buck AK, Dziuk K, Gabelmann A, Reske SN, Hetzel M. Schirrmeister H, et al. Among authors: glatting g. J Nucl Med. 2001 Dec;42(12):1800-4. J Nucl Med. 2001. PMID: 11752076 Free article.

5

Quantification of 18F-FDG uptake in non-small cell lung cancer: a feasible prognostic marker?

Buck AK, Glatting G, Reske SN. Buck AK, et al. Among authors: glatting g. J Nucl Med. 2004 Aug;45(8):1274-6. J Nucl Med. 2004. PMID: 15299047 Free article. No abstract available.

6

Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation.

Zenz T, Schlenk RF, Glatting G, Neumaier B, Blumstein N, Buchmann I, von Harsdorf S, Ringhoffer M, Wiesneth M, Keller F, Kotzerke J, Röttinger E, Stilgenbauer S, Döhner H, Reske SN, Bunjes D. Zenz T, et al. Among authors: glatting g. J Nucl Med. 2006 Feb;47(2):278-86. J Nucl Med. 2006. PMID: 16455634 Free article. Clinical Trial.

7

Imaging prostate cancer with 11C-choline PET/CT.

Reske SN, Blumstein NM, Neumaier B, Gottfried HW, Finsterbusch F, Kocot D, Möller P, Glatting G, Perner S. Reske SN, et al. Among authors: glatting g. J Nucl Med. 2006 Aug;47(8):1249-54. J Nucl Med. 2006. PMID: 16883001 Free article. Clinical Trial.

8

Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemia.

Glatting G, Müller M, Koop B, Hohl K, Friesen C, Neumaier B, Berrie E, Bird P, Hale G, Blumstein NM, Waldmann H, Bunjes D, Reske SN. Glatting G, et al. J Nucl Med. 2006 Aug;47(8):1335-41. J Nucl Med. 2006. PMID: 16883014 Free article.

9

123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell lines.

Reske SN, Deisenhofer S, Glatting G, Zlatopolskiy BD, Morgenroth A, Vogg AT, Buck AK, Friesen C. Reske SN, et al. Among authors: glatting g. J Nucl Med. 2007 Jun;48(6):1000-7. doi: 10.2967/jnumed.107.040337. Epub 2007 May 15. J Nucl Med. 2007. PMID: 17504875 Free article.

10

Choosing the optimal fit function: comparison of the Akaike information criterion and the F-test.

Glatting G, Kletting P, Reske SN, Hohl K, Ring C. Glatting G, et al. Med Phys. 2007 Nov;34(11):4285-92. doi: 10.1118/1.2794176. Med Phys. 2007. PMID: 18072493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters